Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
JM Liu, J Chi - Experimental Biology and Medicine, 2022 - journals.sagepub.com
Cytokine storm is an umbrella term that describes an inflammatory syndrome characterized
by elevated levels of circulating cytokines and hyperactivation of innate and/or adaptive …
by elevated levels of circulating cytokines and hyperactivation of innate and/or adaptive …
[HTML][HTML] Болезнь Стилла взрослых: новые горизонты
ЕЛ Насонов, Е Файст - Научно-практическая ревматология, 2021 - cyberleninka.ru
Болезни Стилла у детей (системный ювенильный идиопатический артрит (ЮИА)) и у
взрослых (болезнь Стилла взрослых (БСВ)) рассматриваются как системные …
взрослых (болезнь Стилла взрослых (БСВ)) рассматриваются как системные …
Diagnosis and investigation of suspected haemophagocytic lymphohistiocytosis in adults: 2023 Hyperinflammation and HLH Across Speciality Collaboration (HiHASC …
MF Cox, S Mackenzie, R Low, M Brown… - The Lancet …, 2024 - thelancet.com
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome
characterised by persistently activated cytotoxic lymphocytes and macrophages, which, if …
characterised by persistently activated cytotoxic lymphocytes and macrophages, which, if …
A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples
R Soltane, N Almulla, A Alasiri, NF Elashmawy… - Biomolecules, 2023 - mdpi.com
COVID-19, caused by the SARS-CoV-2 virus, manifests with a wide range of clinical
symptoms that vary from mild respiratory issues to severe respiratory distress. To effectively …
symptoms that vary from mild respiratory issues to severe respiratory distress. To effectively …
Vaccination against SARS-CoV-2 in patients with inflammatory bowel diseases: where do we stand?
PR Tepasse, R Vollenberg, TM Nowacki - Life, 2021 - mdpi.com
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBDs).
Immunosuppressive medication is the main therapeutic approach to reducing inflammation …
Immunosuppressive medication is the main therapeutic approach to reducing inflammation …
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
W Schmidt, K Pawlak-Buś, B Jóźwiak… - Journal of Clinical …, 2023 - mdpi.com
Hyperinflammation in COVID-19 plays a crucial role in pathogenesis and severity; thus,
many immunomodulatory agents are applied in its treatment. We aimed to identify good …
many immunomodulatory agents are applied in its treatment. We aimed to identify good …
[HTML][HTML] Clinical features and prognostic risk prediction of non-hodgkin lymphoma-associated hemophagocytic syndrome
S Yao, Z Jin, L He, R Zhang, M Liu, Z Hua… - Frontiers in …, 2021 - frontiersin.org
Background Malignancies, especially lymphoma, are a common cause of adult secondary
HLH and an independent risk factor for the prognosis of HLH patients. Methods Patients with …
HLH and an independent risk factor for the prognosis of HLH patients. Methods Patients with …
An immunological Axis Involving Interleukin 1β and leucine-Rich-α2-Glycoprotein reflects therapeutic response of children with Kawasaki Disease: implications from …
C Kessel, I Koné-Paut, S Tellier, A Belot… - Journal of clinical …, 2022 - Springer
Purpose A recent phase II open-label study of the interleukin 1 (IL-1) receptor antagonist (IL-
1Ra) anakinra in treating IVIG-resistant Kawasaki disease (KD) patients reported promising …
1Ra) anakinra in treating IVIG-resistant Kawasaki disease (KD) patients reported promising …
Impaired humoral immunity with concomitant preserved T cell reactivity in IBD patients on treatment with infliximab 6 month after vaccination with the SARS-CoV-2 …
R Vollenberg, PR Tepasse, E Lorentzen… - Journal of Personalized …, 2022 - mdpi.com
Introduction: The Coronavirus Disease 2019 (COVID-19) pandemic has been caused by the
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The most important …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The most important …
Significantly reduced retinol binding protein 4 (RBP4) levels in critically Ill COVID-19 patients
R Vollenberg, PR Tepasse, M Fobker, A Hüsing-Kabar - Nutrients, 2022 - mdpi.com
The SARS-CoV-2 virus is the causative agent of the COVID-19 pandemic. The disease
causes respiratory failure in some individuals accompanied by marked hyperinflammation …
causes respiratory failure in some individuals accompanied by marked hyperinflammation …